Nrg Therapeutics

Nrg Therapeutics company information, Employees & Contact Information

Explore related pages

Nrg Therapeutics email format Nrg Therapeutics management contacts

Related company profiles:

External link for NRG Therapeutics

Company Details

Employees
12
Address
Stevenage, Hertfordshire, Gb
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
http://www.nrgtherapeutics.com
Keywords
(AWS) for their support..
HQ
Stevenage, Hertfordshire
Competitors
Alzheon, Inc., Capsida Biotherapeutics, Immunic Therapeutics, Asceneuron SA, Neumora, Muna Therapeutics, QurAlis, Myricx Bio, Biogen, AviadoBio.
Looking for a particular Nrg Therapeutics employee's phone or email?

Nrg Therapeutics Questions

News

NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies - GlobeNewswire

NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies GlobeNewswire

NRG Therapeutics Ltd bags £50m in Series B financing - European Biotechnology Magazine

NRG Therapeutics Ltd bags £50m in Series B financing European Biotechnology Magazine

UK: NRG Therapeutics announces oversubscribed £50m Series B - Investors in Healthcare

UK: NRG Therapeutics announces oversubscribed £50m Series B Investors in Healthcare

NRG Therapeutics closes £50m Series B round - UKTN

NRG Therapeutics closes £50m Series B round UKTN

NRG Therapeutics raises £50m to tackle neurodegenerative disorders - BusinessCloud

NRG Therapeutics raises £50m to tackle neurodegenerative disorders BusinessCloud

NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND - GlobeNewswire

NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND GlobeNewswire

A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria - BioPharma Dive

A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria BioPharma Dive

NRG Therapeutics: Restoring motor neuron function via mitochondria - BioCentury

NRG Therapeutics: Restoring motor neuron function via mitochondria BioCentury

NRG Therapeutics secures £50M Series B to advance mitochondrial drugs for ALS and Parkinson’s - Tech.eu

NRG Therapeutics secures £50M Series B to advance mitochondrial drugs for ALS and Parkinson’s Tech.eu

NRG Therapeutics Raises £50M Series B Financing - FinSMEs

NRG Therapeutics Raises £50M Series B Financing FinSMEs

NRG Therapeutics banks £50M to take mitochondrial-focused ALS and Parkinson’s drug into the clinic - Tech Funding News

NRG Therapeutics banks £50M to take mitochondrial-focused ALS and Parkinson’s drug into the clinic Tech Funding News

NRG Therapeutics clinches oversubscribed $67m Series B - Business Weekly

NRG Therapeutics clinches oversubscribed $67m Series B Business Weekly

NRG Therapeutics gets grant to test mitochondria-targeting therapy - ALS News Today

NRG Therapeutics gets grant to test mitochondria-targeting therapy ALS News Today

Neuroscience firm looking to slow progression of Parkinson’s and MND closes £50m Series B fundraise - Insider Media Ltd

Neuroscience firm looking to slow progression of Parkinson’s and MND closes £50m Series B fundraise Insider Media Ltd

British Business Bank backs NRG Therapeutics with £8m investment in £50m Series B round - Business Matters

British Business Bank backs NRG Therapeutics with £8m investment in £50m Series B round Business Matters

NRG Therapeutics Selects First Development Candidate, - GlobeNewswire

NRG Therapeutics Selects First Development Candidate, GlobeNewswire

NRG Therapeutics launches Series B after $5m boost from Michael J. Fox Foundation - Business Weekly

NRG Therapeutics launches Series B after $5m boost from Michael J. Fox Foundation Business Weekly

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS - Labiotech.eu

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS Labiotech.eu

Neuroscience firm makes trio of senior appointments - follows £50m Series B raise - Insider Media Ltd

Neuroscience firm makes trio of senior appointments - follows £50m Series B raise Insider Media Ltd

Award to help NRG Therapeutics develop new Parkinson's and Motor Neuron Disease treatments - Labiotech.eu

Award to help NRG Therapeutics develop new Parkinson's and Motor Neuron Disease treatments Labiotech.eu

NRG Therapeutics Secures £50 Million in Series B Financing - Global Legal Chronicle

NRG Therapeutics Secures £50 Million in Series B Financing Global Legal Chronicle

Companies like Nrg Therapeutics

Alzheon, Inc. logo - Similar company to Nrg Therapeutics

Alzheon, Inc.

33
Myricx Bio logo - Similar company to Nrg Therapeutics

Myricx Bio

25
Muna Therapeutics logo - Similar company to Nrg Therapeutics

Muna Therapeutics

56
AviadoBio logo - Similar company to Nrg Therapeutics

Aviadobio

77
QurAlis logo - Similar company to Nrg Therapeutics

Quralis

95
Immunic Therapeutics logo - Similar company to Nrg Therapeutics

Immunic Therapeutics

87
Biogen logo - Similar company to Nrg Therapeutics

Biogen

7.60K
Neumora logo - Similar company to Nrg Therapeutics

Neumora

122
Capsida Biotherapeutics logo - Similar company to Nrg Therapeutics

Capsida Biotherapeutics

93
Asceneuron SA logo - Similar company to Nrg Therapeutics

Asceneuron Sa

15

Top Nrg Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant